#Malaria claims thousands of lives per year and is harder to eradicate. Researchers at Ehime University demonstrate #adjuvant formulations are a key component to developing an effective malaria #vaccine candidate published in @FrontiersIn Immunology #GLASE
RT @MalariaPapers: A novel asexual blood-stage malaria vaccine candidate: PfRipr5 formulated with human-use adjuvants induces potent growth…
RT @MalariaPapers: A novel asexual blood-stage malaria vaccine candidate: PfRipr5 formulated with human-use adjuvants induces potent growth…
A novel asexual blood-stage malaria vaccine candidate: PfRipr5 formulated with human-use adjuvants induces potent growth inhibitory antibodies https://t.co/wD6COdGxUR